Praxis Precision Medicines to Present at H.C. Wainwright 24th Annual Global Investment Conference

Rhea-AI Summary

Praxis Precision Medicines (NASDAQ: PRAX) announced participation in a fireside chat at the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022, at 10:30 a.m. ET. This event will focus on the company's advancements in CNS therapies targeting neuronal excitation-inhibition imbalance. Investors can access the live webcast on the company's website, with a replay available for 90 days after the event. Praxis is developing multiple clinical-stage product candidates for various CNS disorders.

BOSTON, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will participate in a fireside chat at the H.C. Wainwright 24th Annual Global Investment Conference on Wednesday, September 14, 2022 at 10:30 a.m. ET.

The event will be available via live webcast through the Events & Presentations page of the Investors + Media section of the company’s website at www.praxismedicines.com. A replay of the webcast will be available on Praxis’ website for 90 days following the event.

About Praxis
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying insights from genetic epilepsies to both rare and more prevalent neurological disorders, using our understanding of shared biological targets and circuits in the brain. Praxis has established a broad portfolio with multiple programs, including product candidates across movement disorders, epilepsy and psychiatric disorders, with four clinical-stage product candidates. For more information, please visit www.praxismedicines.com and follow us on LinkedIn and Twitter.

FAQ

When will Praxis participate in the H.C. Wainwright conference?

Praxis will participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022, at 10:30 a.m. ET.

Where can I watch the Praxis conference webcast?

The conference webcast can be viewed through the Events & Presentations page on Praxis's website.

How long will the Praxis webcast replay be available?

The replay of the Praxis webcast will be available for 90 days following the event.

What is the focus of Praxis's therapies?

Praxis focuses on developing therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance.

What is the stock symbol for Praxis Precision Medicines?

The stock symbol for Praxis Precision Medicines is PRAX.